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ABSTRACT 
Inflammation was signs of pathological or abnormality in tissue to give an alert as a trouble signal to 
the system. Therapeutic using NSAIDs has some side effects. This research explored the potential role of 
chlorogenic acid as natural therapeutic compound to inhibit the inflammation target such as COX-2 by 
interaction model. The research method used in the study by molecular docking approach, which binds 
ligand and protein. Protein data provided by Protein Data Bank (ID: 6cox) while, chlorogenic acid obtain 
from PubChem (CID: 1794427). We docked COX-2 and chlorogenic acid using Hex 8.0.0. Visualization 
and analysis of the molecular interactions of chlorogenic acid and COX-2 conducted by the Discovery 
Studio Client 4.1 software. Chlorogenic acid has high permeability and is easily absorbed based on five 
Lipinski Rule. Interestingly, we found Fifteen amino acid was binding with chlorogenic acid that formed 
by hydrogen bond and van der Waals. The interaction between ligand-protein results in energy binding-
327.59cal/mol. Chlorogenic acid has a potential role to inhibit inflammation pathway by inhibiting COX-
2. We predicted chlorogenic acid has a potential as therapy anti-inflammatory to suppress COX-2 as 
mediator inflammation. 
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INTRODUCTION 
Inflammation is a physiological response 
to abnormal conditions in the body. 
Inflammation can occur locally, systemically, 
acutely and chronically, causing severe 
pathological abnormalities (Abdulkhaleq et al., 
2018; Phalitakul et al., 2011). When 
inflammation occurs, the body will respond by 
forming anti-inflammatory cytokines to 
produce symptoms of inflammation. Bare et al., 
(2018) in the previous study reported the 
protein profile of all tissues in inflammation 
(type 2 diabetes mellitus) group and the normal 
group was completely diverse as proper by 
Experion Pro260 analysis besides in SDS-
PAGE analysis show same results. 
Inflammation, which happened in human’s 
body correlated with the mediator inflammation 
such as Cyclooxygenase-2 (COX-2). COX-2 
has a function of initiation and maintenance 
during inflammation abnormal physiological 
conditions. These Cyclooxygenase-2 
regulations by stimulating the production of 
prostacyclin (PGI2), also preventing platelet 
aggregation (Al-Saeed, 2011; Knights et al., 
2010). In another study to developed COX-2 
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inhibitor as known as NSAID is aspirin, 
acetylsalicylic acid. Aspirin binds to the COX 
active site and has a higher affinity to Ser-530 
(Smith & Murphy, 2016). 
To therapeutic inflammation in human’s 
body, most people use drugs such as use 
nonsteroidal anti-inflammatory drugs 
(NSAIDs). The drug treatment not only in fever 
and mild pain but also to act by reducing 
chronic inflammatory (Bäck et al., 2012). The 
function of NSAIDs inhibition of COX-2 
(possibly by blocking PGI2 biosynthesis while 
not hindering TXA2 formation (Phalitakul et 
al., 2011). 
Overconsumption of NSAIDs drugs has 
some sides effect such as gastrointestinal, 
cardiovascular risks (Al-Saeed, 2011), adrenal 
atrophy (Phalitakul et al., 2011), and induce the 
risk of atrial fibrillation (Bäck et al., 2012). Due 
to the side effects of the NSAIDs, researchers 
concern to find natural compounds for effective 
and reduce the effects. 
Coffee one of the cultivation in Indonesia. 
Coffee has natural compounds, caffeic acid has 
functions inhibitor COX-2 (Bare et al., 2019a) 
and chlorogenic acid.  Chlorogenic acid is one 
of the chemicals compounds in coffee beans 
(Moon et al., 2009; Watanabe et al., 2006). Shi 
et al., (2013) reported chlorogenic acid has 
potentially associated with various 
inflammatory response inhibition by in vitro 
study in case of reduces liver inflammation and 
fibrosis. Bare et al., (2019b) reported 
chlorogenic acid has a function to inhibit ACE. 
Using the chlorogenic acid expected to reduce 
toxicity and side effects to human body. In this 
paper, we analyze and investigate the potential 
of chlorogenic acid as anti-inflammatory agents 
by inhibiting COX-2 roles used in silico 
approach. 
 
MATERIALS AND METHODS 
Ligand and Protein Preparation. Protein 
Data Bank (PDB) from www.rscb.org was used 
to acquire a database to get 3D COX-2 with ID: 
6cox (Kurumbail et al., 1996), while the 
chemical structure of chlorogenic acid (CID: 
1794427) was acquired from the database of 
PubChem.com. Minimalizing energy 
chlorogenic acid by open babel in PyRx Virtual 
screening tool. Removing ligand from water 
molecules used Discovery Studio Client 4.1. 
Converting ligand from SDF format file to PDB 
file using PyRx Virtual screening tool software. 
Preparation COX-2 by removing ligand that 
binding with protein using Discovery Studio 
Client 4.1. 
Molecular Docking. Ligand chlorogenic 
acid was docked with protein COX-2 by in 
silico. Molecular docking was established using 
Hex 8.0.0 version software. Then ligand and 
protein that docked in HEX, we visualize and 
analyze the molecular interactions of 
chlorogenic acid and COX-2 by Discovery 
Studio client 4.1 software. The analyzation 
including amino acid resides, hydrogen bonds, 
van der Waals and energy binding which 
formed by the interactions. 
 
RESULT AND DISCUSSION 
The chlorogenic acid and COX-2 
interactions were shown the binding of amino 
acid residues with chlorogenic acid. The types 
of chemistry bond, which formed between 
ligand, and amino acid residues are hydrogen 
bonds. Interactions between ligand and protein 
showed fifteen amino acid residues which 
correlating with the chlorogenic acid in B 
domain. The amino acid residues are   HIS207, 
PHE210, LYS211, THR212, ASP213, HIS214, 
LYS215, ARG216, ARG222, ILE274, 
GLN289, GLU290, VAL291, ASN382, 
HIS386 The bond that occurs in amino acid 
residues LYS215, GLU290, ASN382 is 
hydrogen bond type conventional hydrogen 
bond while HIS207 is hydrophobic.  Binding 
between ligand-protein had the energy binding 
-327.59cal/mol. 
Farah et al. (2008) reported chlorogenic 
acid which consumed by the human has highly 
bioavailable in humans. Chlorogenic acid has 
molecular weight 354.311 <500, the value of 
the log coefficient of octanol/water (log P) -
0.6459 > 5, H-receptor (HBA) under 8 and the 
donor H-bond (HBD) 6>5. Chlorogenic acid 
has been clear in humans' metabolism and 
kinetics, furthermore it has high permeability 
and is easily absorbed by the body based on 
Lipinski et al., (1997). In this research, we 
found hydrogen bond, binding chlorogenic 
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acid, and LYS215, GLU290, and ASN382. 
This interaction of those causes the 
disorientation of the substrate. In amino 
residue, HIS207 formed hydrophobic 
interactions, which affect the substrate and 
nucleophile orientation. The distance in 
hydrogen bond that formed in amino acid 
residue LYS215 smaller than amino acid 
residues GLU290 and ASN382 has an effect on 
the strength of the bond.  The smaller distance 
of hydrogen to the acceptor leads, the bond will 
be stronger (Santoso et al., 2016).
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Molecular interaction between chlorogenic acid and COX-2: a. Ligand and protein interactions; b. 3D structure 
interaction. Interactions Van der Waals, unfavorable bump, conventional hydrogen bond, carbon-hydrogen 
bond, and Pi-Pi stacked; c. 2D structure interaction; d. Hydrophobicity complex 
 
The chlorogenic acid has an affinity with 
the activator side of COX-2 in amino acid 
residues, which bind with a hydrogen bond. The 
inflammation pathway was role by COX-2 such 
as PI3K, NF-κβ, and Akt was blocked when 
chlorogenic acid deactivated COX-2 by 
interaction on (active side domain of COX-2) 
(Rachmad et al., 2018).
 
Table 1. Interaction chlorogenic acid and COX-2 protein 
Complexes 
Energy 
(cal/mol) 
Name Distance Category Types 
from 
chemistry 
to 
chemistry 
Chlorogenic 
acid-COX-2 
-327.59 B:LYS215:HN - 
:LIG1:O 
1.78522 Hydrogen 
Bond 
Conventional 
Hydrogen 
Bond 
H-Donor H-Acceptor 
:LIG1:H - 
B:GLU290:OE1 
2.48003 Hydrogen 
Bond 
Conventional 
Hydrogen 
Bond 
H-Donor H-Acceptor 
a b 
c d 
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:LIG1:H - 
B:ASN382:OD1 
2.573 Hydrogen 
Bond 
Conventional 
Hydrogen 
Bond 
H-Donor H-Acceptor 
:LIG1:H - 
B:GLU290:OE1 
1.99185 Hydrogen 
Bond 
Carbon 
Hydrogen 
Bond 
H-Donor H-Acceptor 
B:HIS207 - 
:LIG1 
4.53111 Hydrophobic Pi-Pi Stacked Pi-
Orbitals 
Pi-Orbitals 
B:PHE210:O - 
:LIG1:C 
2.25178 Unfavorable Unfavorable 
Bump 
Steric Steric 
B:PHE210:CB - 
:LIG1:O 
2.25097 Unfavorable Unfavorable 
Bump 
Steric Steric 
 
COX-2 is a central enzyme in the 
biosynthesis of prostaglandins. These activated 
by inflammatory inducements, such as 
cytokines and lipopolysaccharide. In the cell 
metabolic pathway, COX-2 was induced by 
prostaglandin production implicated to increase 
inflammation, matrix tissue remodeling, 
fibrosis progress and expansion of tumor 
genesis (Shi et al., 2013). 
Recently study shown that Ser-530 was 
homolog in COX-1 and COX-2 indicated that 
NSAID was non-selected inhibitors for COX-2 
(Smith & Murphy, 2016). Interestingly, our 
study found another active site that binds 
chlorogenic acid. Chlorogenic acid has activity 
to induce inactivation of COX-2 by the 
interactions in amino acid residues LYS215, 
GLU290, ASN382 and HIS207. 
Compare to affinity character between 
chlorogenic acid and COX-2 in this research 
indicated that interaction was blocking at COX-
2 in different active site location compare to 
other ligand complexes COX-2 NSAID (Perez 
et al., 2019). Different binding sides in COX-2 
have potential role for inhibiting COX-2 
function in different effects compare to 
chemical drugs. 
Interaction leads effectively to reduce 
chronic inflammation that indicated to 
pathophysiological damage. This mechanism 
has been extensively shown in preclinical and 
epidemiological studies that support the 
targeting of the COX-2 pathway for the 
prevention and treatment of malignancy. In 
another study, the blocked activity of COX-2 
and upregulating of PGE2 synthase have 
prevalent roles to inhibit and reducing cancer 
factors progression. Inactivation COX-2 can 
down-regulated these effects through several 
signaling pathways such as stimulation of 
vascular endothelial growth factor (VEGF) 
leading to increased cell proliferation, 
metastatic endothelial and angiogenesis (Xu et 
al., 2014). Another effect can lead to 
upregulating the protooncogenes, BCL-2, and 
the epidermal growth factor receptor (EGFR), 
were mediated by the initiation of the mitogen-
activated protein kinase (MAPK) and the 
phosphoinositide 3-kinase (PI3K)/AKT 
pathway, respectively (Buchanan et al., 2003). 
In some cases, increased transcriptional activity 
of the anti-apoptotic mediator nuclear factor-κB 
(NF-κB) (Poligone & Baldwin, 2001). 
Inactivated COX-2 protein expression in 
target tissue, Pop-Busui et al. (2008) showed 
that inactivation gen of COX-2 in diabetic mice 
with COX-2 specific inhibition in diabetic rats 
prevented nerve conduction deficits. In this 
case, diabetes encouraged production-specific 
biomarkers by oxidative stress and 
inflammation. Systematical effect with 
potential to progression of PG and correlated 
with imbalance in the peripheral nerves. In 
another result also shown that COX-2 gene 
inactivation protects against diabetes-induced 
damage in some targeted tissue (Rachmad et 
al., 2018).   
 
CONCLUSION 
Based on interaction model, Chlorogenic 
acid has potential role as therapeutic agent anti-
inflammation by inhibiting cyclooxygenase-2. 
The interactions between ligand and protein 
formed fifteen amino acid residues, which 
interacted with chlorogenic acid. Besides that, 
we found type of interactions such as hydrogen 
bonds, van der Waals, hydrophobic with the 
energy binding-327.59cal/mol. Inhibiting 
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COX-2 might correlated with oxidative and 
derivate of prostaglandins compound but need 
further study to prove the efficacy of 
chlorogenic acid. 
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